A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment - Module 4: Specialty Care
The fourth learning module addresses more specialized topics in migraine care. It provides a review of medication overuse headache and cluster headache, and explores vestibular migraine and hormone-related migraine issues in depth.
For any non-headache specialist healthcare professionals who encounter patients with migraine.
Upon completion of these activities, participants should be better able to:
- Define a Medication Response, or Overuse, Headache and replacement therapies.
- Describe the presentations of Vestibular Migraine.
- Explain the relationship of Vestibular Migraine to Meniere’s Disease and Benign Paroxysmal Positional Vertigo (BPPV).
- Describe the treatment options for Vestibular Migraine.
- Distinguish Cluster Headache from Migraine.
- Recite the treatment options for Cluster Headache.
- Describe the effects of hormones on migraine
- Distinguish the treatment options for menstrual migraine, pregnancy, breastfeeding and menopause.
- Describe the value and risk factors related to hormonal supplementation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Association of Migraine Disorders. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by Association of Migraine Disorders.
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Contact Hours: 2.0 of which 2.0 are eligible for pharmacology credit.
- 2.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 2.00 ANCC
- 2.00 Participation